News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Drops WUXI XDC (02268.HK) TP to $85.9 as 2026 Guidance in Line
WUXI XDC (02268.HK) reported 2H25 results that were largely in line with its earlier alert, with revenue increasing by 35.9% YoY, and net profit ring by 26.4% to RMB735 million, Go...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Drops WUXI XDC (02268.HK) TP to $85.9 as 2026 Guidance in Line
Close
Recommend
2
Positive
0
Negative
1
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

WUXI XDC (02268.HK)  -0.550 (-0.891%)    Short selling $65.27M; Ratio 67.631%   reported 2H25 results that were largely in line with its earlier alert, with revenue increasing by 35.9% YoY, and net profit ring by 26.4% to RMB735 million, Goldman Sachs published a research report saying.

The management's 2026 guidance was in line with expectations. At a constant exchange rate, based on a comparable basis (including BioDlink CDMO business for both years), 2026 revenue will grow by approx. 35%. On a pro forma basis (assuming the BioDlink acquisition is completed by the end of March, compared to WUXI XDC's standalone business in 2025), the growth is expected to be 40%.

Goldman Sachs raised its 2026-2028 adjusted net profit forecasts for WUXI XDC by +1.8%/ +1.4%/ -0.1%, reflecting the commencement of production at the Singapore plant, although partially offset by depreciation and amortization costs mostly recognized in 2027.

Therefore, the broker kept rating at Buy, and dropped its target price from $87.1 to $85.9.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.